Skip to content Skip to footer

Research Portal of the TU Dresden

Chimeric antigen receptor-engineered primary natural killer cells: a tool to improve adoptive tumor immunotherapy

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

Achim Temme - , Department of Neurosurgery, German Cancer Consortium (Partner: DKTK, DKFZ), University Hospital Carl Gustav Carus Dresden, German Cancer Research Center (DKFZ) (Author)
Marc Schmitz - , Institute for Immunology, National Center for Tumor Diseases (Partners: UKD, MFD, HZDR, DKFZ), University Hospital Carl Gustav Carus Dresden, German Cancer Research Center (DKFZ) (Author)

Details

Original language	English
Pages (from-to)	983-986
Number of pages	4
Journal	Immunotherapy
Volume	8
Issue number	9
Publication status	Published - Sept 2016
Peer-reviewed	Yes

External IDs

PubMed	27485071
Scopus	84981167177

Keywords

Keywords

Animals, Combined Modality Therapy, Cytotoxicity, Immunologic, Genetic Engineering, Genetic Therapy, Humans, Immunotherapy, Adoptive/methods, Killer Cells, Natural/physiology, Neoplasms/immunology, Receptors, Antigen/genetics, Recombinant Fusion Proteins/genetics